ClearTrial will examine solutions to the budgeting, forecasting, and operational planning challenges presented by adaptive studies. These challenges include creating multiple and varied trial scenarios accounting for shifting resource allocations, timelines, treatment arms, and more.
Chicago (PRWEB) January 15, 2009 -- ClearTrial (www.cleartrial.com), a leading provider of clinical trial software for clinical trial operations planning, budgeting, and outsourcing, announced today that Deirdre BeVard, ClearTrial Vice President of Clinical Services, will speak at the CBI Forecasting & Budgeting conference at the Crowne Plaza Hotel in Philadelphia, February 3-4, 2009. BeVard will address the rapidly growing use of adaptive trial design in clinical development, focusing on helping life sciences companies address the unique challenges this approach poses for accurate forecasting, budgeting, and operational planning.
While promising significant benefits such as better safety and efficacy data and faster drug development with lower costs, adaptive clinical trials place a far greater burden on planning and initial trial design. Adaptive trials are challenging to forecast and budget since planners must create multiple and varied trial scenarios accounting for shifting resource allocations, timelines, treatment arms, and more. In addition, adaptive trials place a greater burden than traditional trials on certain areas such as biostatistics, data management, and project management.
Attendees of this session will discover:
-Common design principles of adaptive trials and their operational impact
-Practical guidelines for accurately forecasting and budgeting adaptive trials
-The importance of activity-based planning to successful adaptive trial forecasting and budgeting
Copyright©2009 Vocus, Inc.
All rights reserved